Jigar Raythatha

Jigar Raythatha

Director/Miembro de la Junta en
Flare Therapeutics, Inc.
.
49 años
Health Technology
Consumer Services
Finance

Perfil

Jigar Raythatha is currently Director at TRIANA Biomedicines, Inc., Director at Flare Therapeutics, Inc. since 2023, and Partner at Third Rock Ventures LLC since 2021.
Former positions include President, Chief Executive Officer & Director at Constellation Pharmaceuticals, Inc. from 2017 to 2021; Chairman at Jounce Therapeutics, Inc. from 2022 to 2023; Chief Business Officer at Jounce Therapeutics, Inc. from 2012 to 2017; Principal at Biogen MA, Inc., Pfizer Inc., Shire Regenerative Medicine, Inc., and Red Abbey Venture Partners LLC from 2005 to 2009; and Board Member at American Cancer Society, New England Division, Inc. Education includes an MBA from Columbia Business School and The Trustees of Columbia University in The City of New York, and an undergraduate degree from Rutgers State University of New Jersey conferred in 1998.

Cargos activos de Jigar Raythatha

EmpresasCargoInicio
Inversor de Capital Privado 01/01/2021
Director/Miembro de la Junta -
Director/Miembro de la Junta 30/03/2023

Antiguos cargos conocidos de Jigar Raythatha.

EmpresasCargoFin
JOUNCE THERAPEUTICS, INC. Presidente 03/05/2023
CONSTELLATION PHARMACEUTICALS, INC. Director Ejecutivo 15/07/2021
JOUNCE THERAPEUTICS, INC. Corporate Officer/Principal 01/02/2017
American Cancer Society, New England Division, Inc.
Director/Miembro de la Junta -
PFIZER INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Jigar Raythatha.

Formación de Jigar Raythatha.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

66

Relaciones de 1er grado

13

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas13

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Health Technology

American Cancer Society, New England Division, Inc.

Health Technology

Consumer Services

Health Technology

Health Technology